• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Dechra acquires veterinary marketing and distributions rights for Equine ProVet APC

September 27, 2021
dvm360 Staff
dvm360, dvm360 November 2021, Volume 52,

The global specialist in veterinary pharmaceuticals will have an exclusive license for equine ProVet APC and ProVet BMC.

Dechra Veterinary Products—a global specialist in veterinary pharmaceuticals and related products business—recently announced its acquisition of an exclusive license from Hassinger Biomedical for equine ProVet APC (Autologous Platelet Concentrate) and ProVet BMC (Bone Marrow Concentrate).

“ProVet APC has become the most highly sought-after regenerative system for equine athletes,” said Amy Hassinger, CEO of Hassinger Biomedical, in a company release. “We believe Dechra is especially poised through its experience in the veterinary sector to meet the growing global demand by veterinarians and their clients for the ProVet APC and BMC Regenerative Therapy System."

According to the release, the 2 patented medical devices concentrate platelets or bone marrow in 90 seconds with a processing time of 2.5 minutes from start to finish. The technology found within ProVet APC has been found to consistently deliver 6 to 8mls of a 7.8 higher concentration of platelet-rich plasma and can have a healing concentrate obtained from 54mls of whole blood in the 60ml system.

“The medical industry has long recognized that harnessing the growth factors found in platelets positively enhances healing results and reduces recovery time in soft tissue injuries,” said Mike Eldred, president of Dechra North America, in the release.

“These 2 products will be great additions to our equine product line and further strengthen our market position in veterinary regenerative medicine,” he continued.

Advertisement

Additionally, the acquisition of equine ProVet APC products will further accompany Dechra’s rthokine® Vet IRAP joint therapy and offer veterinarians a comprehensive tool for their regenerative medicine needs.

To learn more about Dechra, go here.

References

Dechra Acquires Exclusive License from Hassinger Biomedical for Equine ProVet APC™. News release. Dechra Veterinary Products. September 22, 2021. Accessed September 27, 2021. [email].

download issueDownload Issue: dvm360 November 2021

Related Content:

BusinessEquineEquine MedicineProductsdvm360 November 2021
CityVet Celina opens in Prosper, Texas
CityVet Celina opens in Prosper, Texas
Animal biomedical device company announces new senior technical services veterinarian
Animal biomedical device company announces new senior technical services veterinarian
Four ways to curb no shows
Four ways to curb no shows

Advertisement

Latest News

Can our Pride panel answer these LGBTQ+ trivia questions?

Creating inclusive spaces for the LGBTQ+ community in vet med

Happy Pride Month, Hill's launches Prescription Diet ONC Care, and more

CityVet Celina opens in Prosper, Texas

View More Latest News
Advertisement